Osl asx

Financial Times Close. Search the FT Search. Show more World link World.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech.

Osl asx

OncoSil Medical Limited. OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. About the company. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OSL Stock Overview OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Rewards Risk Analysis. Earnings have declined by Shareholders have been substantially diluted in the past year. Has less than 1 year of cash runway. New major risk - Market cap size Jan New major risk - Market cap size Oct New major risk - Share price stability Oct

Necessary cookies are absolutely essential for the website to function properly. Top Stories, osl asx. To access these valuable tools and see the full perspective, subscribe now.

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board.

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance. Media centre. ASX rulebooks. ASX Compliance. ASX regulatory framework.

Osl asx

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets. Show more Opinion link Opinion. Show more Personal Finance link Personal Finance.

Slime purchase

Nigel received his Bachelor of Arts from York University, Ontario in and followed on with a Bachelor of Commerce from the University of Windsor, Ontario where he graduated in David also directed a patient advocacy campaign which successfully lobbied the UK government to substantially increase funding for oncology drugs and services in the NHS. For Individual Investors. Show more Opinion link Opinion. Oct OncoSil Medical Ltd. Market resources. To benefit from this content, plus our exclusive data archive, subscribe to the FT today. Any information that you receive via FT. Search the FT Search. He trained in general internal medicine, medical oncology and radiation oncology and completed a Phd on DNA damage repair.

OncoSil Medical Ltd is an Australia-based medical device company seeking to advance radiation for cancer patients.

ASX Market Report. View Valuation. We keep shareholders informed through ASX announcements, the company website, regular newsletters and our annual report. Professor Sharma is also a honorary consultant in clinical oncology at University College London Hospitals, where he has a clinical practice in radiotherapy and chemotherapy. Subscribers benefit from access to:. Morningstar Direct. Prior to joining OncoSil, Nicole was a Global Regulatory Affairs Manager at Sirtex Medical, focusing on preparation and maintenance of international product registrations for their brachytherapy device. Trade our cash market. Christian has extensive experience with listed and private companies includes corporate secretarial, accounting and general management through The CFO Solution and previous roles. Upcoming Dividends. Track sectors and industries performance, see top performing companies, and find news relevant to you. Morningstar equity research methodology. Targeted Approach Positive Impact Learn how. Price to Earnings Ratio vs Industry. Getting started.